Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Return on Assets (2018 - 2025)

Autolus Therapeutics (AUTL) has disclosed Return on Assets for 7 consecutive years, with 0.27% as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Return on Assets rose 23.0% year-over-year to 0.27%, compared with a TTM value of 0.27% through Dec 2024, up 23.0%, and an annual FY2024 reading of 0.38%, up 10.0% over the prior year.
  • Return on Assets was 0.27% for Q4 2024 at Autolus Therapeutics, up from 0.31% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.06% in Q4 2021 and bottomed at 0.5% in Q4 2023.
  • Average Return on Assets over 5 years is 0.27%, with a median of 0.28% recorded in 2024.
  • The sharpest move saw Return on Assets dropped -22bps in 2022, then increased 23bps in 2024.
  • Year by year, Return on Assets stood at 0.22% in 2020, then skyrocketed by 73bps to 0.06% in 2021, then crashed by -380bps to 0.28% in 2022, then tumbled by -77bps to 0.5% in 2023, then skyrocketed by 45bps to 0.27% in 2024.
  • Business Quant data shows Return on Assets for AUTL at 0.27% in Q4 2024, 0.31% in Q3 2024, and 0.5% in Q4 2023.